|Titre :||Synthetic cannabinoid poisoning: A growing health concern (2016)|
|Auteurs :||J. PHILLIPS ; F. LIM ; R. HSU|
|Type de document :||Article : Périodique|
|Dans :||Nursing (Vol.46, n°11, November 2016)|
|Article en page(s) :||34-41|
|Discipline :||PRO (Produits, mode d'action, méthode de dépistage / Substances, action mode, screening methods)|
Thésaurus TOXIBASECANNABINOIDES ; DROGUES DE SYNTHESE ; INTOXICATION ; NEUROBIOLOGIE ; EFFET SECONDAIRE ; ETUDE DE CAS ; APPAREIL CARDIOVASCULAIRE ; PRISE EN CHARGE ; SANTE PUBLIQUE
Globally, the use and abuse of synthetic cannabinoids increased alarmingly in the last few years. Synthetic cannabinoids are drugs that possess some of the properties of delta-9-tetrahydrocannabinol (THC), the main psychoactive constituent of natural marijuana.
In the 1980s, the chemistry professor John Huffman developed a synthetic cannabinoid, known as JWH-018. The original intent was to enhance understanding of the cannabinoid system. In what experts now call a classic case of research "hijacking," synthetic cannabinoids have been developed by unscrupulous manufacturers into a potent and potentially lethal drug of abuse sold under many names, including spice, K2, fake weed, Yucatan fire, skunk, moon rocks, black mamba, and crazy clown. When consumed (smoked or ingested), these products elicit psychoactive effects similar to those of marijuana. This article provides an overview of this emerging public health threat, illustrated by a case report.
|Domaine :||Drogues illicites / Illicit drugs|
|Refs biblio. :||34|
|Affiliation :||NewYork-Presbyterian Hospital/Weill-Cornell Medical Center, USA|